SymBio Pharmaceuticals Debt 2024

SymBio Pharmaceuticals Aktienanalyse

What does SymBio Pharmaceuticals do?

SymBio Pharmaceuticals Ltd is a company specializing in the development and marketing of medical products. The company, based in Japan, was founded in 2005 and currently employs over 300 employees. SymBio Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding SymBio Pharmaceuticals's Debt Structure

SymBio Pharmaceuticals's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing SymBio Pharmaceuticals's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to SymBio Pharmaceuticals’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in SymBio Pharmaceuticals’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about SymBio Pharmaceuticals stock

What is the debt of SymBio Pharmaceuticals this year?

SymBio Pharmaceuticals has a debt level of -6,517.01 JPY this year.

What was the debt of SymBio Pharmaceuticals compared to the previous year?

The debt of SymBio Pharmaceuticals has increased by 3.73% compared to the previous year increased.

What are the consequences of high debt for investors in SymBio Pharmaceuticals?

High debt can pose a risk for investors of SymBio Pharmaceuticals, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of SymBio Pharmaceuticals?

Low debt means that SymBio Pharmaceuticals has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from SymBio Pharmaceuticals affect the company?

An increase in debt of SymBio Pharmaceuticals can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of SymBio Pharmaceuticals affect the company?

A reduction in debt of SymBio Pharmaceuticals can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of SymBio Pharmaceuticals?

Some factors that can influence the debt of SymBio Pharmaceuticals include investments, acquisitions, operating costs, and revenue development.

Why are the debts of SymBio Pharmaceuticals so important for investors?

The debts of SymBio Pharmaceuticals are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can SymBio Pharmaceuticals take to change the debt?

To change the debt, SymBio Pharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does SymBio Pharmaceuticals pay?

Over the past 12 months, SymBio Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, SymBio Pharmaceuticals is expected to pay a dividend of 0 JPY.

What is the dividend yield of SymBio Pharmaceuticals?

The current dividend yield of SymBio Pharmaceuticals is .

When does SymBio Pharmaceuticals pay dividends?

SymBio Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of SymBio Pharmaceuticals?

SymBio Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of SymBio Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.

In which sector is SymBio Pharmaceuticals located?

SymBio Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von SymBio Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of SymBio Pharmaceuticals from 9/14/2024 amounting to 0 JPY, you needed to have the stock in your portfolio before the ex-date on 9/14/2024.

When did SymBio Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/14/2024.

What was the dividend of SymBio Pharmaceuticals in the year 2023?

In the year 2023, SymBio Pharmaceuticals distributed 0 JPY as dividends.

In which currency does SymBio Pharmaceuticals pay out the dividend?

The dividends of SymBio Pharmaceuticals are distributed in JPY.